1. Home
  2. CNTX vs DSY Comparison

CNTX vs DSY Comparison

Compare CNTX & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • DSY
  • Stock Information
  • Founded
  • CNTX 2015
  • DSY 2020
  • Country
  • CNTX United States
  • DSY China
  • Employees
  • CNTX N/A
  • DSY N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • CNTX Health Care
  • DSY
  • Exchange
  • CNTX Nasdaq
  • DSY Nasdaq
  • Market Cap
  • CNTX 78.0M
  • DSY 72.0M
  • IPO Year
  • CNTX 2021
  • DSY N/A
  • Fundamental
  • Price
  • CNTX $0.79
  • DSY $1.05
  • Analyst Decision
  • CNTX Strong Buy
  • DSY
  • Analyst Count
  • CNTX 5
  • DSY 0
  • Target Price
  • CNTX $5.25
  • DSY N/A
  • AVG Volume (30 Days)
  • CNTX 145.6K
  • DSY 35.7K
  • Earning Date
  • CNTX 08-06-2025
  • DSY 01-01-0001
  • Dividend Yield
  • CNTX N/A
  • DSY N/A
  • EPS Growth
  • CNTX N/A
  • DSY 120.37
  • EPS
  • CNTX N/A
  • DSY 0.01
  • Revenue
  • CNTX N/A
  • DSY $7,323,356.00
  • Revenue This Year
  • CNTX N/A
  • DSY N/A
  • Revenue Next Year
  • CNTX N/A
  • DSY N/A
  • P/E Ratio
  • CNTX N/A
  • DSY $85.22
  • Revenue Growth
  • CNTX N/A
  • DSY 16.37
  • 52 Week Low
  • CNTX $0.49
  • DSY $0.95
  • 52 Week High
  • CNTX $2.70
  • DSY $6.98
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 58.08
  • DSY 30.92
  • Support Level
  • CNTX $0.68
  • DSY $1.07
  • Resistance Level
  • CNTX $0.73
  • DSY $1.15
  • Average True Range (ATR)
  • CNTX 0.05
  • DSY 0.11
  • MACD
  • CNTX -0.00
  • DSY -0.01
  • Stochastic Oscillator
  • CNTX 55.65
  • DSY 0.00

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: